Vol.2, No.10, 1174-1178 (2010) Health
doi:10.4236/health.2010.210172
Copyright © 2010 SciRes. Openly accessible at http://www.scirp.org/journal/HEALTH/
What are the top most costly diseases for USA? The
alignment of burden of illness with prevention and
screening expenditures
Guvenc Kockaya1*, Albert Wertheimer2
1Istanbul University, Istanbul Medical Faculty, Pharmacology and Clinical Pharmacology, Istanbul, Turkey; *Corresponding Author:
guvenckockay a@y ahoo.com
2Temple University, School of Pharmacy, Center for Pharmaceutical Health Services Research, Philadelphia, USA
Received 2 July 2010; revised 12 July 2010; accepted 20 July 2010.
ABSTRACT
Background: It was the intention of the authors
to generate a list of the top diseases respon-
sible for the greatest financial expense in the
United States. This listing would then inform
polic-ymakers as to the highest priority target
conditions. With such information available,
funding for the NIH could be accomplished bas-
ed upon factual criteria rather than political
clout or uninformed consensus. Method: The
first step was a literature review to explore arti-
cles and reports which were published about
the cost of illness (COI) up to December 2009.
Therefore the source of the data used in this
investigation was obtained from this retros-
pective search approach. Results: With refer-
ence to total cost for disease, first was HCVD
with 475.3 billion US dollars, followed by alcohol
abuse and substance at 300.6 billion US dollars,
digestive diseases at 259.6 billion US dollars,
cancer at 239.5 billion US dollars and mental
disease at 216,6 billion US dollars. Conclusion:
As has been seen, the total societal costs of the
diseases do not synch with the degree of atten-
tion paid to these various disease states. Sev-
eral of the diseases have very powerful and
vocal support organizations that encourage at-
tention and clinical research support. On the
other hand we hear very little about efforts
against allergic rhinitis or infectious and par-
asitic diseases.
Keywords: Cost of Illness; Burden of Illness
1. BACKGROUND AND INTRODUCTION
It is difficult to avoid seeing examples of promotional ca-
mpaigns encouraging women to self examine for poten-
tial breast cancer or advertisements for asthma, erectal
dysfunction, GERD or hypertension medications. In fact
during a typical day, many people are exposed to prom-
otional messages regarding prevention, screening and/or
treatment of a number of acute and chronic medical con-
ditions. Logically speaking, it would seem rational to de-
termine which diseases or medical conditions are the
most costly to the society and then focus our attention on
avoiding, treating or eliminating those medical conditi-
ons. But, in fact, as we know, the extent of advocacy ag-
ainst various problems is determined by a number of va-
riables which may include the political connections of
those involved, the fame or celebrity of a recent death
from a condition or the recent diagnosis in a Hollywood
star or famous athlete, or a whole host of other variables
which may or may not have any serious connection to
the priority of that particular disease state.
Apparently, upon the request of the US Senate, a stu-
dy was undertaken which was published by the National
Institutes of Health in the year 2000 where a large num-
ber of diseases were arrayed according to their total
burden of cost upon the US society [1]. A study of this
nature makes perfect sense since the Congress appropri-
ates funds to support the various institutes of the NIH.
Surely these legislators wanted to be certain that the
disease states they were funding research and education
for were the ones which should be tackled as a priority
in the United States.
Also a study was published by Bloom [2] in the year
2001. They searched 1725 published study reports which
included 80 different diseases from the year 1985 to
1999 and reported 17 different disease costs.
So it has been nearly 10 years since these studies were
conducted and many of the flaws and shortcomings of
the 2000 report may be corrected today given the far
greater extent of available data and knowledge.
However, every year the NIH publishes direct and in-
G. Kockaya et al. / Health 2 (2010) 1174-1178
Copyright © 2010 SciRes. Openly accessible at http://www.scirp.org/journal/HEALTH/
117
1175
direct costs of 12 different main diseases categories [3].
There were not any published studies such as this one,
which includes 19 main diseases with some subgroups
resulting in a list of 32 different disease states. That ma-
kes this study unique.
1.1. The Study
It was the intention of the authors to generate a list of the
top diseases responsible for the greatest financial expe-
nse in the United States. This listing would then inform
policymakers as to the highest priority target conditions.
With such information available, funding for the NIH
could be accomplished based upon factual criteria rather
than political clout or uninformed consensus.
2. METHODOLOGY
The first step was a literature review to explore articles
and reports which were published about the cost of ill-
ness (COI) up to December 2009. Therefore the source
of the data used in this investigation was obtained from
this retrospective search approach. Also, it must be men-
tioned that there are a number of approaches for the cal-
culation of the cost of illness. Some of these approaches
are based on only direct costs and some are inclusive of
only indirect costs. Clabaugh and Ward [4] reported that
most COI studies included only one component.
The differences in data sources that influenced calcu-
lations were reported by them. We learned that the most
frequently used data sources were from insurance or
employer claims data and the second most commonly
used approach involved publicly available data sets from
the and NCHS or from the Agency for Healthcare Re-
search and Quality. Considering that there are very many
approaches, we defined the COI studies which would be
employed. In our definition, COI studies, reviews or
reports must include direct, indirect and total costs. We
did not evaluate the data source used in preparing the
COI numbers. Because of these limitations for the cal-
culation of COI, incomplete numbers were used from
various sources and matched together.
The first review included PubMed and the website for
each diseases Society. Also used were the websites of
the centers for disease control and prevention, and the
National Institutes of Health support for selected disea-
ses and conditions report. From these sources a listing of
55 different diseases was created. In the end we searched
8491 published documents. To be included it was deter-
mined that a study would have to adhere to the following
criteria:
a defined US national population
report published in English in a peer reviewed journal
conclusion of cost of illness data between 1999 and
December 2009
inclusion of the direct, indirect and total costs of
diseases
inclusion of all diseases with costs higher than one
billion US dollars
inclusion of the latest data.
Included only those studies which were intended to
shed light on the cost of illness question. Studies or re-
ports which included economic outcome data such as
cost-effectiveness or cost utility were ex-polluted. The
studies which did not include all of the direct, indirect
and total cost of diseases were also excluded and the
NIH 2000 numbers were employed if no data subsequent
to 1999 could be located.
In the end we listed 19 main diseases with some sub-
groups resulted in a list of 32 different disease states. All
costs were adjusted to 2009 US dollars by using a yearly
5% inflation rate factor to adjust up to 2009.
3. RESULTS
The list of cost of diseases may be seen in Table 1. We
found that depression is the most articles and published
journals about its cost of illness with 987 articles. De-
pression was followed by cancer (972), diabetes (747),
mental disease (559) and schizophrenia (419), next was
stroke with 410, asthma with 399, AIDS, 395, arthritis,
378 and tobacco/smoking related death and disease at
311 (Table 2).
Regarding only direct costs, the most costly disease was
heart and cardiovascular disease (HCVD) with 313.8
billion US dollars, it was followed by digestive diseases
at 220.8 billion US dollars, mental disease 175.7 billion
US dollars; nervous system diseases 153.3 billion US
dollars; diabetes 128,3 billion US dollars the complete
list is seen in Table 3.
Similarly, the most costly indirect expenses these dis-
eases was alcohol abuse and dependence 218.5 billion
US dollars; HCVD at 161.4 billion US dollars; cancer
141.5 billion US dollars; tobacco/smoking related death
and disease 101.85 billion US dollars and Alzheimer`s
disease 94 billion US dollars. The top five are seen in
Table 4.
With reference to total cost for disease, first was HC-
VD with 475.3 billion US dollars, followed by alcohol
abuse and substance at 300.6 billion US dollars, diges-
tive diseases at 259.6 billion US dollars, cancer at 239.5
billion US dollars and mental disease at 216,6 billion US
dollars the complete list is seen in Table 5.
4. CONCLUSIONS
As has been seen, the total societal costs of the diseases
G. Kockaya et al. / Health 2 (2010) 1174-1178
Copyright © 2010 SciRes. Openly accessible at http://www.scirp.org/journal/HEALTH/
1176
Table 1. Estimated cost of illness of the USA in 2009 from highest to lowest total cost.
N Disease Direct Costsa Indirect Costa Total Costsa
1 Heart & CVD [5] 313.8 161.4 475.3
CHD [5]183 121.6 304.6
Hypertension [5]54.2 19.2 73.4
Stroke [5]45.9 23 68.9
2 Alcohol Abuse and Dependence [1] 82 218.5 300.6
3 Digestive Disease [6] 220.8 38.8 259.6
4 Cancer [7] 97.8 141.5 239.5
Breast Cancer [1]10.7 10 20.8
Cervical Cancer [7]5.5 0.6 6.1
5 Mental Disease [6] 175.7 40.9 216.6
Depression [8]40.4 88.4 128.9
Schzophrenia [9]31.9 45.5 88.2
6 Tobacco(smoking)-related Death and Disease [10] 100.8 101.8 202.6
7 Diabetes [11] 127.8 63.9 191.8
8 Lung Diseases [6] 113.6 63.8 177.4
Chronic Obstructive Pulmonary Disease [12]27.8 33.1 49.5
Asthma [12]14.6 5.8 20.5
9 Diseases of the Nervous System [6] 153.3 23.7 177
Parkinson`s Disease [13]9.7 22.6 32.3
Migraine [14]1.6 21.1 22.8
Epilepsy [15]9.5 0.1 9.6
10 Rheumotoid Artritis [16] 108.6 62.9 171.2
11 Alzheimer [3] 54 94 148
12 Arthritis [1] 24.7 80.7 105.5
13 Infectious and Parasitic Diseases [6] 44 41.3 85.3
14 Over Active Bladder [17] 22.3 33.5 55.8
15 Viral Respiratory Tract Infections (non influenza) [18] 22.7 30.1 53.6
16 AIDS [19] 9.4 41.7 51.2
17 Influenza [20] 11.4 17.9 40.4
18 Alergic Rhinitis [21] 7.3 6.1 13.5
19 Sexual Transmitted Disease [22] 9.1 0.9 10
aUS Dollars in billions & numbers are rounded
Table 2. The list of top 10 most cost-of illness published articles.
Diseases Article Numbers
Depression 987
Cancer 972
Diabetes 747
Mental Diseases 559
Schizophrenia 419
Stroke 410
Asthma 399
AIDS 395
Arthritis 378
Tobacco (Smoking)-Related Death and Disease 311
G. Kockaya et al. / Health 2 (2010) 1174-1178
Copyright © 2010 SciRes. Openly accessible at http://www.scirp.org/journal/HEALTH/
117
1177
Table 3. The list of top 5 most direct costly diseases.
Diseases Direct Costs (in billion US
dollars)
Heart & CVD 313.8
Digestive Diseases 220.8
Mental Diseases 175.7
Diseases of the Nervous System 153.3
Diabetes 128.3
Table 4. The list of top 5 most indirect costly diseases.
Diseases Direct Costs
(in billion US dollars)
Alcohol Abuse and Dependence 218.5
Heart & CVD 161.4
Cancer 141.5
Tobacco(Smoking)-Related
Death and Disease 101.85
Alzheimer 94
Table 5. The list of top 5 most total cost diseases.
Diseases Direct Costs
(in billion US dollars)
Heart & CVD 475.3
Alcohol Abuse and Dependence 300.6
Digestive Diseases 259.6
Cancer 239.5
Mental Diseases 216.6
do not synch with the degree of attention paid to these
various disease states. Several of the diseases have very
powerful and vocal support organizations that encourage
attention and clinical research support.
On the other hand we hear very little about efforts ag-
ainst allergic rhinitis or infectious and parasitic diseases.
In this study we learned that the most serious, fatal or te-
rminal conditions are not always the ones most detrim-
ental to the national economy. Probably more days are
lost from work for diseases such as low back pain the
common cold, seasonal flu, among others. Some of these
so-called trivial or limited conditions may have serious
economic consequences and therefore should not be
automatically dismissed.
However, depression has the most articles found in our
search, and its total cost is US$128.9 billion. This cost
gives it a place in the middle of the total cost list. Also it
is the same as AIDS, which is in the lower end of the
cost list, but it is on the top of the published article list.
Same explanation is in order for breast cancer and cer-
vical cancer, as well. However much is said about taking
action for breast or cervical cancer, yet direct, indirect
and total costs for them are not as high for the society as
chronic obstructive pulmonary disease (COPD) or as
attention deficit hyperactivity disorder (ADHD) which
were not even mentioned as much as breast cancer or
cervical cancer.
On the other hand, alcohol abuse & dependence and
digestive diseases are in the top of the cost list. But, in so-
ciety they are rarely spoken about as much as other dis-
eases. Also they aren’t in the top of the articles list. Be-
cause of its high costs, there is much publicity about
prevention of digestive diseases and awareness projects
about food safety or washing hands. For alcohol abuse &
dependence, there are projects about decreasing alcohol
consumption like increasing the tax on alcohol or hold-
ing seminars in schools about alcohol abuse & depend-
ence, for creating public awareness.
Our study also shows that the best matched diseases
are Heart & CVD, Cancer and Mental Diseases. They
are in the top of the cost list and in the top of article list.
Also \frequently, we can see a project on television, in
newspapers or journals for increasing public awareness.
Because if we can increase awareness of an illness,
people may care about it and they may go to their physi-
cian regarding their signs and symptoms and be more
compliant with their treatment. All of this may decreases
the cost of illness to the reimbursement companies and
to society.
By following our study findings, it could said that we
need to care more about alcohol or tobacco dependence,
digestive diseases such as heart and CVD, cancer or
mental diseases.
REFERENCES
[1] Kirschtein, R. (2000) Disease-Specific Estimates of
Direct and Indirect Costs of Illness and Department of
Health and Human Services NIH Support, Washington
DC. http://ospp.od.nih.gov/ecostudie s/COIreport web.htm
[2] Bloom, B.S., Bruno, D.J., Maman, D.Y. and
Jayadevappa, R. (2001) Usefulness of US cost-of-ıllness
studies. Healthcare Decision Making Pharmacoeco-
nomics, 19(2), 207-213.
[3] Alzheimer’s Association (2009) Alzheimer’s disease
facts and figures. Alzheimers Dement, 5(3), 234-270.
[4] Clabaugh, G. and Ward, M.M. (2008) Cost-of-illness
studies in the United States: A systematic review of
methodologies used for direct cost value. Health, 11(1),
13-21.
[5] (2009) A Report from the American Heart Association
Statistics Committee and stroke statistics subcommittee
heart disease and stroke statistics. Update Circulation,
119, e21-e181.
[6] (2008) National Institutes of Health National Heart, Lung
G. Kockaya et al. / Health 2 (2010) 1174-1178
Copyright © 2010 SciRes. Openly accessible at http://www.scirp.org/journal/HEALTH/
1178
and Blood Institute Fact Book Fiscal Year, US De-
partment of Health and Human Services, Washington,
DC. www.nhlbi.nih.gov/about/factbook/FactBookFinal.
pdf
[7] Lipsy, R.J. and Pharm, D. (2008) BCPS, FASHP
assessing the short-term and long-term burden of ıllness
in Cervical cancer. American Journal of Managed Care,
14, S177-S184.
[8] Greenberg, P.E. and Kessler, R.C. (2003) The economic
burden of depression in the United States: How did it
change between 1990 and 2000? Journal of Clinical
Psychiatry, 64(12), 1465-1475.
[9] Wu, E.Q., Birnbaum, H.G., Shi, L., Ball, D.E., Kessler,
R.C., Moulis, M. and Aggarwal, J. (2005) The economic
burden of Schizophrenia in the United States in 2002,
Journal of Clinical Psychiatry, 66(9 ), 1122-1129.
[10] Fiore, M.C., Jaén, C.R., Baker, T.B., et al. (2009)
Treating tobacco use and dependence: 2008 date. quick
reference guide for clinicians. Rockville, Department of
Health and Human Services. Public Health Service.
http://www.ahrq.gov/clinic/tobacco/tobaqrg.pdf
[11] (2008) American Diabetes Association Economic Costs
of Diabetes in the U.S. in 2007. Diabetes Care, 31,
596-615.
[12] (2004) National heart, lung, and blood ınstitute. Mor-
bidity and mortality: 2004 chartbook on cardiovascular,
lung, and blood diseases. US Department of Health and
Human Services, Washington, DC.
[13] Huse, D.M., Schulman, K., Orsini, L., Castelli-Haley, J.,
Kennedy, S. and Lenhart, G. (2005) Burden of illness in
Parkinson’s disease. Movement Disorders, 20, 1449-
1454.
[14] Henry, X. and Hu, M.D. (1999) Burden of Migraine in
the United States. Archives of Internal Medicine, 159,
813-818.
[15] Yoon, D., Frick, K.D., Carr, D.A. and Austin, J.K. (2009)
Economic impact of epilepsy in the United States.
Epilepsia, 50(10), 2186-2191.
[16] Yelin, E., Murphy, L., Cisternas, M.G., Foreman, A.J.,
Pasta, D.J., Helmick, C.G. (2007) Medical care ex-
penditures and earnings loses among persons with
arthritis and other rheumatic condition in 2003. Arthritis
and Rheumatism, 56(5), 1397-1407.
[17] Onukwugha, E. and Zuckerman, I.H. (2009) The total
economic burden of overactive bladder in the United
States: A disease-specific approach. American Journal of
Managed Care, 15(4 Suppl.), S90-S97.
[18] Fendrick, A.M. and Monto, A.S. (2003) The economic
burden of non-influenza-related viral respiratory tract
infection in the United States. Arch Intern Med., 163(4),
487-494.
[19] Hutchinson, A.B., Farnham, P.G., Dean, H.D., Ekwueme,
D.U., del Rio, C., Kamimoto, L., et al. (2006) The
economic burden of HIV in the United States in the era
of highly active antiretroviral therapy: Evidence of
continuing racial and ethnic differences. Journal of Ac-
quired Immune Deficiency Syndromes, 43(4), 451-457.
[20] Molinari, N.A. and Ortega-Sanchez, I.R. (2007) The
annual impact of seasonal influenza in the US:
Measuring disease burden and costs. Vaccine, 25(27),
5086-5096.
[21] Malone, D.C., Lawson, K.A., Smith, D.H., Arrighi, H.M.,
Battista, C. (1997) A cost of illness study of allergic
rhinitis in the United States. Journal of Allergy and
Clinical Immunology, 99(1 Pt 1), 22-27.
[22] Chesson, H.W., Blandford, J.M., Gift, T.L., Tao, G. and
Irwin, K.L. (2004) The estimated direct medical cost of
sexually transmitted diseases among American youth, 2000
perspectives on sexual and reproductive health. 36(1),
11-19.